Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy
ACS Applied Materials & Interfaces · 14.02.2024 · 16 (6) · 6689-6708
DOI: 10.1021/acsami.3c15686 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 01.02.2024. Verfasst von Zongquan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China. Hauptthemen laut MEDLINE: Metabolic Reprogramming, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 162 Literaturangaben. Gefördert von: Southwest Medical University, Sichuan Province Science and Technology Support Program, Hejiang County People's Hospital.
Abstract (Originalsprache)
Tumor development and metastasis are closely related to the complexity of the metabolism network. Recently, metabolism reprogramming strategies have attracted much attention in tumor metabolism therapy. Although there is preliminary success of metabolism therapy agents, their therapeutic effects have been restricted by the effective reaching of the tumor sites of drugs. Nanodelivery systems with unique physical properties and elaborate designs can specifically deliver to the tumors. In this review, we first summarize the research progress of nanodelivery systems based on tumor metabolism reprogramming strategies to enhance therapies by depleting glucose, inhibiting glycolysis, depleting lactic acid, inhibiting lipid metabolism, depleting glutamine and glutathione, and disrupting metal metabolisms combined with other therapies, including chemotherapy, radiotherapy, photodynamic therapy, etc. We further discuss in detail the advantages of nanodelivery systems based on tumor metabolism reprogramming strategies for tumor therapy. As well as the opportunities and challenges for integrating nanodelivery systems into tumor metabolism therapy, we analyze the outlook for these emerging areas. This review is expected to improve our understanding of modulating tumor metabolisms for enhanced therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China.
- Department of Thyroid and Vascular Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
- Basic Medicine Research Innovation Center for Cardiometabolic Disease, Ministry of Education, Southwest Medical University, Luzhou, Sichuan 646000, China.
ORCID-Profile: Chunhong Li
Förderung
- Southwest Medical University
- Sichuan Province Science and Technology Support Program
- Hejiang County People's Hospital
- Luzhou Municipal People's Government
Zitieren
APA
Zhang, Z., Liang, X., Yang, X., Liu, Y., Zhou, X., & Li, C. (2024). Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy. ACS Applied Materials & Interfaces, 16(6), 6689-6708. https://doi.org/10.1021/acsami.3c15686
Vancouver
Zhang Z, Liang X, Yang X, Liu Y, Zhou X, Li C. Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy. ACS Applied Materials & Interfaces. 2024;16(6):6689-6708. doi:10.1021/acsami.3c15686
BibTeX
@article{Zhang2024,
author = {Zhang, Zongquan and Liang, Xiaoya and Yang, Xi and Liu, Yan and Zhou, Xiangyu and Li, Chunhong},
title = {Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {6},
pages = {6689--6708},
doi = {10.1021/acsami.3c15686}
}
EUVIMED